Cancer Center Amsterdam
-
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial: a randomised, open-label, multicentre, phase 3 trial
DANUBE study investigators, van der Heijden, M. S., Lee, J. L., Eigl, B. J., Mukherjee, S. D., Suarez, C., Westgeest, H., Flechon, A., Ou, Y.-C., Park, I., Matveev, V., Pérez-Valderrama, B., Cheng, S., Frank, S., Anido, U., Hamzaj, A., Retz, M., Sridhar, S., Scagliotti, G. V. & Voortman, J. & 2 others, , Dec 2020, In: lancet oncology. 21, 12, p. 1574-1588 15 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Jansen, B. H. E., Cysouw, M. C. F., Vis, A. N., van Moorselaar, R. J. A., Voortman, J., Bodar, Y. J. L., Schober, P. R., Hendrikse, N. H., Hoekstra, O. S., Boellaard, R. & Oprea-Lager, D. E., 1 Sept 2020, In: Journal of nuclear medicine. 61, 9, p. 1320-1325 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Hepatic morphopathologic findings of lead poisoning in a drug addict: A case report
Verheij, J., Voortman, J., Van Nieuwkerk, C. M. J., Jarbandhan, S. V. A., Mulder, C. J. J. & Bloemena, E., 2009, In: Journal of gastrointestinal and liver diseases. 18, 2, p. 225-227 3 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications